MDM for pharma company

BEDMINSTER, NEW JERSEY: Cegedim Dendrite announced that a major global company specializing in generic and branded pharmaceuticals has contracted with Cegedim Dendrite for master data management (MDM) services in the U.S. via Nucleus360 as a Service.

It claims itself to be the only Life Sciences-specific MDM available as a service, and that Nucleus360 as a Service improves business efficiency and fosters compliance by providing a centralized reference for managing critical customer master data across the entire enterprise.

One of the greatest challenges of Life Sciences sales and marketing organizations is maintaining an accurate and consistent customer database. Life Sciences companies typically have multiple databases from disparate systems. Customer information constantly changes and is often captured and managed differently within the same organization. Companies seek relief for internal resources charged with the arduous task of continuously maintaining thousands of customer records while linking the data to create accurate customer master views that drive business decisions.

“Accurate customer information is the lifeblood of Customer Relationship Management for pharmaceutical companies,” said Bill Buzzeo, Cegedim Dendrite Vice President & General Manager, Compliance and OneKey Solutions. “Furthermore, quality customer data is essential, and also difficult to achieve because it is constantly in flux due to healthcare providers’ changing business affiliations, updates in compliance and regulatory requirements, as well as other professional and personal factors. Together with providing a unique view of customers across multiple data sources, Cegedim Dendrite has extensive capabilities to enhance and validate our clients’ data based on a best practices framework developed by our experienced industry experts. Our customers can truly rely on the data.”